News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Shelley Wood November 28, 2016
News Conference News AHA 2016 Stress Testing May Be Increasing Among Younger Patients With Commercial Health Insurance L.A. McKeown November 23, 2016
News Conference News AHA 2016 La Pruebas de Esfuerzo podrían estar Aumentando en Pacientes Más Jóvenes con Seguro Médico Comercial L.A. McKeown November 23, 2016
News Conference News AHA 2016 PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad Michael O'Riordan November 15, 2016
Presentation AHA 2016 GLAGOV Trial: Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound Presenter: Steven E. Nissen November 15, 2016
Presentation AHA 2016 FUnctional Testing Underlying REvascularization: The FUTURE trial Presenter: Gilles Rioufol November 15, 2016
News Conference News AHA 2016 Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery Michael O'Riordan November 15, 2016
News Conference News AHA 2016 Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study Michael O'Riordan November 14, 2016
News Conference News AHA 2016 Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis Michael O'Riordan November 13, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016